|
Match
|
Document |
Document Title |
|
|
6150086 |
Encapsulation of oleophilic substances and compositions produced thereby
Multiple micro-encapsulations of a high concentration oleophilic substance using heat to set the primary particle renders the composition suitable for the production of free-flowing powders or...
|
|
|
6143910 |
Methods for preparation and use of 1α, 24(S) -dihydroxy vitamin D2
1α,24(S)-Dihydroxy vitamin D 2 which is useful as an active compound of pharmaceutical compositions for the treatment of disorders of calcium metabolism and for various skin disorders. The...
|
|
|
6127559 |
2-alkyl-19-nor-vitamin D compounds
This invention provides a novel class of vitamin D related compounds, namely, the 2-alkyl-19-nor-vitamin D derivatives, as well as a general method for their chemical synthesis. The compounds have...
|
|
|
6124276 |
Vitamin D derivative with substituent at the 2β-position
1α-hydroxy-vitamin D derivatives represented by formula ##STR1## wherein R 1 represents a hydrogen atom or a hydroxyl group; and R 2 represents a straight-chain or branched C 2 -C 7 alkyl, C 2...
|
|
|
6121469 |
Therapeutically effective 1α,25-dihydroxyvitamin D.sub.3 analogs
Novel analogs of 1α,25-dihydroxyvitamin D 3 which are selective agonists for the genomic responses or agonists or antagonists for the rapid cellular responses in a wide array of diseases in which...
|
|
|
6080879 |
Hexafluoro-vitamin synthesis and crystallization method, solvent and product
This invention provides a novel synthesis and crystallization method and solvent for producing hexafluoro-vitamin D compounds, including 26, 26, 26, 27, 27, 27-hexafluoro-1α, 25-dihydroxyvitamin D...
|
|
|
6072062 |
Synthesis of C.sub.18 -modified vitamin D compounds and compounds resulting therefrom
The invention relates to a new vitamin D compound, substituted in the 18-position with an alkyl group, a hydroxy group, an alkoxy group, an alkenyl group, an alkynyl group, a fluorinated alkyl...
|
|
|
6043386 |
Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D.sub.3
Fluorinated analogs of 1α,25-dihydroxyvitamin D 3 . These analogs are synthesized in a convergent manner by joining A-ring and C,D-ring fragments. Each hybrid analog, having a calcemia-lowering...
|
|
|
6042855 |
Use of vitamin D, its metabolites and analogs to improve tenderness of meat and meat products
A method of improving the tenderness of meat and meat products is described. The method includes administering excessive doses of vitamin D to meat producing animals prior to slaughter. The vitamin...
|
|
|
6043385 |
Vitamin D derivatives
The present invention relates to vitamin D derivatives of the formula I ##STR1## wherein X is CCH 2 or CH 2 ; Y is hydrogen, fluorine or hydroxy Z is hydroxy n is 1 or 2 R 1 is...
|
|
|
6030963 |
16-ene-26,27-bishomo cholecalciferols
The invention relates to a compound of the formula ##STR1## wherein A is ##STR2## Et is ethyl, and R is hydroxy and R 1 is hydrogen or CH 2 or R is hydrogen or fluoro and R 1 is CH 2 ....
|
|
|
6028208 |
Vitamin D.sub.3 derivative and treating agent for inflammatory respiratory disease using same
Provided are vitamin D 3 derivatives expressed by the following general formula [1] ##STR1## [wherein, R 1 and R 2 are each a hydrogen atom, a trialkylsilyl group, an acetyl group, a...
|
|
|
6025346 |
1α-hydroxy vitamin D.sub.4 and novel intermediates and analogues
Disclosed is 1α,24-dihydroxy vitamin D 4 having the following structure: ##STR1## and pharmaceutical compositions containing said compound. The compound and composition are useful in the...
|
|
|
6017908 |
3-EPI vitamin D.sub.2 compounds and uses thereof
Novel 3-epi vitamin D2 compounds having the orientation of the substituent attached to the carbon at position 3 of the A-ring of vitamin D2 inverted from a beta (β) to an alpha (α) configuration...
|
|
|
5994569 |
Dihomo-seco-cholestanes
Polyunsaturated 24a,24b-dihomo-9,10-secocholestane derivatives of formula ##STR1## wherein A is a single or double bond, B 1 and B 2 are each independently CHCH or C.tbd.C, T is CH 2 or...
|
|
|
5981780 |
19-nor-vitamin D.sub.3 compounds with calcemic activity
The 26 and/or 27 homologated analogs of 19-nor-1α,25-dihydroxyvitamin D 3 are disclosed as having relatively high calcemic activity. The 26 and/or 27 homologated analogs showed strong in vivo...
|
|
|
5972917 |
1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
The invention provides 1α-hydroxyvitamin D compounds in which the C-25 or equivalent position of the C-17 side chain has a double bond and method for their use in the treatment and prophylaxis of...
|
|
|
5939408 |
Vitamin D.sub.3 analogs
Compounds of the formula ##STR1## wherein R is hydrogen, fluorine, or hydroxyl, each R 2 is lower alkyl or C(R 3 ) 3 and R 3 is halogen, X is CH 2 or when R is hydroxy, X is hydrogen or...
|
|
|
5936105 |
14-EPI-19-nor-vitamin D compounds and methods
19-nor-vitamin D analog compounds and a method of synthesizing such compounds are disclosed. More particularly, examples of such compounds include 14-epi-19-nor-1α,25-dihydroxyvitamin D 3 ,...
|
|
|
5932565 |
Vitamin D analogues
The invention relates to compounds of formula (I): ##STR1## wherein Q and R are as defined in the specification. The compounds are useful in the treatment of a number of disorders including...
|
|
|
5929056 |
Vitamin D compounds and method of preparing these compounds
The present invention relates to vitamin D compounds of the general formula ##STR1## wherein: R 1 is a hydrogen atom or a hydroxy group; R 2 is a (C 1 -C 3 )alkyl group, a hydroxy(C 1 -C 3...
|
|
|
5905074 |
Vitamin D derivative
A compound of the formula ##STR1## useful for treating vitamin D dependent disorders.
|
|
|
5902806 |
Crystalline vitamin D derivative
A crystalline (5Z,7E,23S)-26,26,26,27,27,27-hexafluoro-9,10-secocholesta-5
,7,10(19)-trie n-1α,3β,23,25-tetraol monohydrate has an excellent preservation stability, and is therefore useful as a...
|
|
|
5891865 |
Treatment of arthritic disease induced by infectious agents
A method of treating arthritis symptoms induced by an infectious agent of an arthritis patient comprising administering to an arthritis patient an amount of vitamin D compound effective to reduce...
|
|
|
5888994 |
Fluorinated Vitamin D.sub.3 analogs
A compound of formula I ##STR1## wherein R is hydrogen, fluorine or hydroxy, and X is CH 2 or when R is hydroxy, X is hydrogen or CH 2 which are useful in the treatment of...
|
|
|
5883271 |
2-Substituted vitamin D derivatives
A compound represented by general formula (I): ##STR1## wherein R 1 and R 2 , each presents an ethyl group and R 3 represents an alkoxy group having (1) to (7) carbon atoms which may be...
|
|
|
5880113 |
19-nor-vitamin D compounds
This invention provides a novel class of vitamin D-related compounds, namely the 1c-hydroxy-19-nor-vitamin D analogs, as well as a general method for their chemical synthesis. The compounds exhibit...
|
|
|
5880114 |
Treatment of immune deficiency with vitamin D compounds
A method for treating immune deficiency in a mammal by administering an amount of a vitamin D compound, such as Vitamin D 3 , its active form 1α,25-dihydroxyvitamin D 3 or other compounds...
|
|
|
5872113 |
Fluorinated vitamin D3 analogs
Fluorinated Vitamin D 3 analogs, intermediates for their preparation, compositions comprising the analogs and methods of treatment of osteoporosis and related conditions with these and related...
|
|
|
5869472 |
Synthesis of 1α-hydroxy vitamin D
A method for 1α-hydroxylation of vitamin D compounds using the appropriate vitamin D as the starting material. The method requires no separatory procedures prior to the actual hydroxylation step.
|
|
|
5856536 |
Preparation of 19-Nor-vitamin D compounds
Disclosed are 20-epi-19-nor-vitamin D compounds having the structure: ##STR1## where each of X 1 and X 2 independently represents hydrogen or a hydroxy-protecting group, and Z represents various...
|
|
|
5843927 |
18,19-dinor-vitamin D compounds
18,19-dinor-vitamin D 3 analogs in which the angular methyl group attached to carbon 13 of the CD-ring and the exocyclic methylene group attached to carbon 10 of the A-ring have been removed and...
|
|
|
5840938 |
20(S)-25-hydroxy vitamin D compounds
Vitamin D 3 analogs in which the methyl group normally attached to the side chain at carbon 20 has been exchanged with the hydrogen atom to form the 20-epi configuration. The compounds are...
|
|
|
5840718 |
22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
The invention relates to a compound of the formula ##STR1## wherein R is hydroxy and R 1 is H 2 or CH 2 or R is hydrogen or fluoro and R 1 is CH 2 and (b) an inert carrier. Compounds of...
|
|
|
5824811 |
22-Thiavitamin D.sub.3 derivatives
Compounds of the general formula: ##STR1## wherein R 1 represents a C1-10 alkyl group which may be substituted by one or more hydroxyl groups, R 2 represents a hydrogen atom or a hydroxyl group,...
|
|
|
5817648 |
Vitamin D.sub.3 analogues having an unsaturated side chain
Vitamin D 3 analogues of the formula (I): ##STR1## wherein R 1 is hydrogen or hydroxy, R 2 is hydrogen, (C 1 -C 3 ) alkyl, phenyl, or trifluoromethyl, R 3 is branched or unbranched (C 1 -C 4...
|
|
|
5811562 |
Vitamin-D amide derivatives
The present invention relates to compounds of general formula (I) ##STR1## where R 1 and R 2 , which may be the same or different, each represent a hydrogen atom or an aliphatic, cycloaliphatic,...
|
|
|
5786347 |
Vitamin D amine and amide derivatives
The invention relates to vitamin D amine and amide derivatives of general formula ##STR1## where R represents a hydrogen atom, an aliphatic, cycloaliphatic or araliphatic group, or an acyl group...
|
|
|
5767111 |
18-nor-vitamin D compounds
18-nor-vitamin D 3 analogs in which the angular methyl group attached to carbon 13 of the CD-ring has been removed and replaced by a hydrogen atom. The 18-nor vitamin D compounds are characterized...
|
|
|
5763428 |
Methods of treating skin disorders with novel 1a-hydroxy vitamin D.sub.4 compounds and derivatives thereof
The disclosure is of methods of treating various skin disorders, including skin cancer, with compounds of novel 1α-hydroxy vitamin D 4 and novel analogues, thereof, including 1,25 dihydroxy...
|
|
|
5756783 |
1α-Hydroxy-24-EPI-vitamin D.sub.4
1α-Hydroxy-24-epi-vitamin D 4 and novel intermediates formed in a novel method of preparing this compound. The method includes campesterol as a starting material which is converted to...
|
|
|
5753638 |
Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
Compounds of the formula ##STR1## wherein R is hydrogen, hydroxy, or fluorine are useful as agents for the treatment of hyperproliferative disorders of the skin such as psoriasis, as agents for the...
|
|
|
5750517 |
Method of treating sebaceous gland diseases with vitamin D.sub.3 fluorinated analogs
Compounds of the formula ##STR1## wherein R is hydrogen, hydroxy, or fluorine are useful as agents for the treatment of hyperproliferative disorders of the skin such as psoriasis, as agents for the...
|
|
|
5750746 |
Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
The invention provides new 24, 26, and/or 27 homologated vitamin D 2 compounds, such as 26,27-dihomo-1α-hydroxyvitamin D 2 , 26,27-dihomo-1α-hydroxy-24-epivitamin D 2 ,...
|
|
|
5726330 |
Highly crystalline 22-oxavitamin D derivatives
Highly crystalline vitamin D derivatives are represented by the formula: ##STR1## (where R 1 is a straight or branched C 4 -C 9 alkyl group optionally having a hydroxyl group; R 2 and R 3 ...
|
|
|
5719297 |
Vitamin D.sub.3 derivatives and production process thereof
A vitamin D 3 derivative represented by the following formula: ##STR1## wherein, R is, independently, a hydrogen atom, tri(C 1 to C 7 hydrocarbon)silyl group, C 2 to C 8 acyl group, or group...
|
|
|
5700791 |
Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof
The invention relates to vitamin D derivatives, modified in 20-position, of general formula I ##STR1## in which X, Y, Z, R 1 , R 2 as well as R 3 have the meaning indicated in the description,...
|
|
|
5698714 |
Process for the preparation of 9, 10-secocholesta-5,7,10 (19)-trienes
The invention recites a process for preparing 9,10-secocholesta-5,7,10(19)-trienes of formula (I) ##STR1## where R 1 is hydrogen or a hydroxy-protecting group and R 2 and R 3 are independently...
|
|
|
5691328 |
Phosphoethanolamine conjugates of vitamin D compounds
Certain phosphoethanolamine conjugates of vitamin D compounds are disclosed wherein the phosphoethanolamine moiety is bonded at the 3-position of the vitamin D moiety. The conjugates exhibit...
|
|
|
5665716 |
24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom
New 24-homo vitamin D derivatives of formula I ##STR1## are described, in which R 1 means a hydrogen atom, a hydroxy, an alkanoyloxy group with 1 to 8 carbon atoms or an aralkanoyloxy group with...
|